Search research articles
Contact Us
Filters
Showing results (71-80 of 338) with videos related to
Page
of 34
Sort By:
Oncotarget
|
February 18, 2017
Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway
Santosh Kumar Singh, Saswati Banerjee, Edward P Acosta, et al.
Biomedica : Revista Del Instituto Nacional De Salud
|
October 22, 2004
[Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia]
María M Torres, Claudia P Acosta, Diana M Sicard, et al.
Pharmacotherapy
|
July 3, 1999
Indinavir concentrations and antiviral effect
E P Acosta, K Henry, L Baken, et al.
JAMA
|
May 29, 2003
Analysis of generic nevirapine products in developing countries
Scott R Penzak, Edward P Acosta, Michele Turner, et al.
JASA Express Letters
|
May 8, 2024
Impact of speech rate on perception of vowel and consonant duration by bilinguals and monolinguals
Miwako Hisagi, Eve Higby, Mike Zandona, et al.
Acta Tropica
|
May 22, 2002
Difficulties and strategies in the control of schistosomiasis in the Philippines
Lydia R Leonardo, Luz P Acosta, Remigio M Olveda, et al.
AIDS (London, England)
|
June 17, 2005
Indinavir protein-free concentrations when used in indinavir/ritonavir combination therapy
Jennifer R King, John G Gerber, Courtney V Fletcher, et al.
Journal of Experimental Pharmacology
|
May 18, 2016
Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptives
Amanda Marie James, Jennifer R King, Ighovwerha Ofotokun, et al.
The Pediatric Infectious Disease Journal
|
March 12, 2025
Examining Neutropenia During Treatment of Cytomegalovirus Disease in Neonates
Javier K Nishikawa, Inmaculada Aban, Edward P Acosta, et al.
HIV Clinical Trials
|
July 28, 2009
Steady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen from 200 mg to 100 mg once daily (TELEX II)
David A Parks, H Clay Jennings, Christopher Taylor, et al.
Page
of 34
Search research articles
Search
Showing results (71-80 of 338) with videos related to
Sort By:
Page
of 34
Oncotarget
|
February 18, 2017
Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway
Santosh Kumar Singh, Saswati Banerjee, Edward P Acosta, et al.
Biomedica : Revista Del Instituto Nacional De Salud
|
October 22, 2004
[Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia]
María M Torres, Claudia P Acosta, Diana M Sicard, et al.
Pharmacotherapy
|
July 3, 1999
Indinavir concentrations and antiviral effect
E P Acosta, K Henry, L Baken, et al.
JAMA
|
May 29, 2003
Analysis of generic nevirapine products in developing countries
Scott R Penzak, Edward P Acosta, Michele Turner, et al.
JASA Express Letters
|
May 8, 2024
Impact of speech rate on perception of vowel and consonant duration by bilinguals and monolinguals
Miwako Hisagi, Eve Higby, Mike Zandona, et al.
Acta Tropica
|
May 22, 2002
Difficulties and strategies in the control of schistosomiasis in the Philippines
Lydia R Leonardo, Luz P Acosta, Remigio M Olveda, et al.
AIDS (London, England)
|
June 17, 2005
Indinavir protein-free concentrations when used in indinavir/ritonavir combination therapy
Jennifer R King, John G Gerber, Courtney V Fletcher, et al.
Journal of Experimental Pharmacology
|
May 18, 2016
Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptives
Amanda Marie James, Jennifer R King, Ighovwerha Ofotokun, et al.
The Pediatric Infectious Disease Journal
|
March 12, 2025
Examining Neutropenia During Treatment of Cytomegalovirus Disease in Neonates
Javier K Nishikawa, Inmaculada Aban, Edward P Acosta, et al.
HIV Clinical Trials
|
July 28, 2009
Steady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen from 200 mg to 100 mg once daily (TELEX II)
David A Parks, H Clay Jennings, Christopher Taylor, et al.
Page
of 34